NIAID supports six clinical trial networks that conduct domestic and international human studies focused on the Institute’s highest HIV/AIDS research priorities including
The clinical trial networks include
Each network consists of a clinical trial unit led by a principal investigator and features an administrative component, community advisory board, and one or more clinical research sites, such as medical schools, academic health centers, hospitals, or outpatient centers, where the clinical trials are performed. For a complete listing of all of the clinical trial units and sites, see: HIV/AIDS Network Clinical Trials Units (CTU) and Clinical Research Sites (CRS).
In addition to the six HIV/AIDS clinical trial networks, NIAID also conducts early stage HIV vaccine research through the Dale and Betty Bumpers Vaccine Research Center (VRC) on the National Institutes of Health campus in Bethesda, Maryland. The VRC Clinical Trials Core Laboratory performs Phase I human research of HIV vaccines developed at VRC.
For information about current federally funded and privately sponsored HIV/AIDS clinical trials, see AIDSinfo or ClinicalTrials.gov.
NIAID supports investigator-initiated epidemiological research as well as a number of targeted programs and several large HIV/AIDS epidemiological cohort studies.
back to top
Last Updated July 21, 2015